EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitHistorischer BeitragOpen Access · CC BY 4.0

Perspectives on the History and Epidemiology of the Varicella Virus Vaccine and Future Challenges

Masayuki Nagasawa iD

Pathogens · 16.08.2025 · 14 (8) · 813

DOI: 10.3390/pathogens14080813 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 16.08.2025. Verfasst von Masayuki Nagasawa. Beteiligte Einrichtung: Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, 1-5-45 Bunkyo-ku, Tokyo 113-8519, Japan. Hauptthemen laut MEDLINE: Chickenpox Vaccine, Chickenpox, Herpesvirus 3, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The varicella attenuated virus vaccine, developed in Japan in the 1970s, has dramatically reduced the number of pediatric chickenpox cases over the past 30 years due to its widespread use. However, a small number of cases of chickenpox, shingles, aseptic meningitis, and acute retinal necrosis caused by vaccine strains have been reported. There are also issues that need to be addressed, such as breakthrough infections and the persistence of the preventive effect of vaccination. In addition, there is the possibility of the emergence of revertants or mutations in the vaccine strain. In recent years, subunit vaccines have been developed, their immune-stimulating effects have been demonstrated, and they are being applied clinically. In addition, development of an mRNA varicella vaccine is underway. In this review, the history and impact of the varicella vaccine are overviewed, as well as its future challenges.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chickenpox VaccineChickenpoxHerpesvirus 3, HumanHumansHistory, 20th CenturyHistory, 21st CenturyJapanVaccines, AttenuatedVaccination

Stichwörter der Autor:innen

COVID-19 pandemicOka strainattenuated live virus vaccinechickenpoxlatent infectionshinglesvaricella zoster virus

Substanzen

Chickenpox VaccineVaccines, Attenuated

Autor:innen und Institutionen

  • Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, 1-5-45 Bunkyo-ku, Tokyo 113-8519, Japan.

ORCID-Profile: Masayuki Nagasawa

Zitieren

APA

Nagasawa, M. (2025). Perspectives on the History and Epidemiology of the Varicella Virus Vaccine and Future Challenges. Pathogens, 14(8), 813. https://doi.org/10.3390/pathogens14080813

Vancouver

Nagasawa M. Perspectives on the History and Epidemiology of the Varicella Virus Vaccine and Future Challenges. Pathogens. 2025;14(8):813. doi:10.3390/pathogens14080813

BibTeX
@article{Nagasawa2025,
  author = {Nagasawa, Masayuki},
  title = {Perspectives on the History and Epidemiology of the Varicella Virus Vaccine and Future Challenges},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {8},
  pages = {813},
  doi = {10.3390/pathogens14080813}
}
Kostenlos starten →